[Multidimensional characteristics of the tumor microenviron-ment and advances in targeted delivery strategies]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanChen H, Zhang L, Li C.
europepmc +1 more source
[Clinical Progress and Prospects of mRNA Tumor Drugs]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanChen J +5 more
europepmc +1 more source
[Research progress in liver cancer in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiMiao TG, Nan YM.
europepmc +1 more source
[Construction of a prognosis forecasting model for immuno-therapy response in cancer patients by integrating routine clinical parameters and tumor mutational burden]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanZhu X, Hao S, Cheng Z, Fang W.
europepmc +1 more source
[Primary hepatic neuroendocrine neoplasms: a case series analysis of 10 patients and literature review]. [PDF]
Zhejiang Da Xue Xue Bao Yi Xue BanJiang Y +5 more
europepmc +1 more source
[Disseminated intravascular coagulation secondary to generalized lymphatic anomaly: a case report]. [PDF]
Zhonghua Xue Ye Xue Za ZhiGao XM, Zhang L.
europepmc +1 more source
[<i>Qingjie Fuzheng</i> Granules alleviates 5-fluorouracil-induced skeletal muscle injury in tumor-bearing mice by inhibiting mitochondria-dependent apoptosis and activating the AMPK-PGC-1α pathway]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoZhao J +5 more
europepmc +1 more source
[Advances in intra-abdominal vascularized lymph node transfer for treatment of limb lymphedema]. [PDF]
Zhongguo Xiu Fu Chong Jian Wai Ke Za ZhiChen Y, Deng C.
europepmc +1 more source
[Occurrence risk of extrahepatic liver tumor with hepatitis B virus infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiZhao DL, Wei L.
europepmc +1 more source
[Research progress in the role of STMN1 in tumor]. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanMa X, Li M, Chen, Mei H, Rong Z.
europepmc +1 more source